Evaluating the Effects of Treatment Conversion for Huntington’s Chorea
Overnight treatment conversion from tetrabenazine to deutetrabenazine in patients with HD was found to be safe.
Chorea
Tardive Dyskinesia Treatment Approved by FDA
Valbenazine is the first drug approved for the treatment of tardive dyskinesia, an adverse effect associated with the use of some antipsychotic medications.
Austedo Approved for Huntington’s Chorea
Deutetrabenazine is only the second drug approved for patients with Huntington’s disease.
